|
Name |
Diaporine A
|
Molecular Formula | C30H22O14 | |
IUPAC Name* |
14-(2,9-dihydroxy-12-methoxy-5-methyl-7,11-dioxo-4,13-dioxatetracyclo[8.5.0.03,8.012,14]pentadeca-1(10),2,5,8-tetraen-14-yl)-2,9-dihydroxy-12-methoxy-5-methyl-4,13-dioxatetracyclo[8.5.0.03,8.012,14]pentadeca-1(10),2,5,8-tetraene-7,11-dione
|
|
SMILES |
COC12OC1(C13OC1(OC)C(=O)c1cc4oc(C)cc(=O)c4c(O)c1C3O)C(O)c1c(cc3oc(C)cc(=O)c3c1O)C2=O
|
|
InChI |
InChI=1S/C30H22O14/c1-9-5-13(31)19-15(41-9)7-11-17(21(19)33)25(37)27(29(39-3,43-27)23(11)35)28-26(38)18-12(24(36)30(28,40-4)44-28)8-16-20(22(18)34)14(32)6-10(2)42-16/h5-8,25-26,33-34,37-38H,1-4H3/t25-,26-,27+,28?,29+,30?/m1/s1
|
|
InChIKey |
LRQHODJQXLXCSC-RKCUPODSSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 606.49 | ALogp: | 1.3 |
HBD: | 4 | HBA: | 14 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 219.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 44 | QED Weighted: | 0.245 |
Caco-2 Permeability: | -5.761 | MDCK Permeability: | 0.00000993 |
Pgp-inhibitor: | 0.304 | Pgp-substrate: | 0.994 |
Human Intestinal Absorption (HIA): | 0.964 | 20% Bioavailability (F20%): | 0.527 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.068 | Plasma Protein Binding (PPB): | 71.72% |
Volume Distribution (VD): | 0.846 | Fu: | 17.63% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.993 |
CYP2C19-inhibitor: | 0.017 | CYP2C19-substrate: | 0.883 |
CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.034 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.163 |
CYP3A4-inhibitor: | 0.053 | CYP3A4-substrate: | 0.939 |
Clearance (CL): | 1.364 | Half-life (T1/2): | 0.027 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.108 |
Drug-inuced Liver Injury (DILI): | 0.982 | AMES Toxicity: | 0.672 |
Rat Oral Acute Toxicity: | 0.923 | Maximum Recommended Daily Dose: | 0.784 |
Skin Sensitization: | 0.356 | Carcinogencity: | 0.986 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.056 |
Respiratory Toxicity: | 0.085 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000922 | 0.387 | D06GCK | 0.260 | ||||
ENC001501 | 0.372 | D0FX2Q | 0.240 | ||||
ENC002093 | 0.372 | D04ITO | 0.234 | ||||
ENC000912 | 0.363 | D03RTK | 0.226 | ||||
ENC003507 | 0.363 | D0G7IY | 0.222 | ||||
ENC003154 | 0.356 | D04AIT | 0.219 | ||||
ENC004244 | 0.343 | D01XWG | 0.219 | ||||
ENC003641 | 0.343 | D0G4KG | 0.218 | ||||
ENC002002 | 0.333 | D06NSS | 0.215 | ||||
ENC001411 | 0.331 | D0G3DL | 0.213 |